医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
八氢-6-(苯基甲基)-1H-吡咯并[3,4-b]吡啶-1-羧酸 1,1-二甲基乙酯 | tert-butyl 6-benzyloctahydro-1H-pyrrolo[3,4-b]pyridine-1-carboxylate | 159877-35-7 | C19H28N2O2 |
|
八氢-2H-喹啉-1-甲醇 | lupinine | 10159-79-2 | C10H19NO |
|
八氢-2,6-甲桥-2H-茚并[5,6-b]环氧乙烯 | 5,6-epoxy-octahydro-4,7-methano-indene | 6004-36-0 | C10H14O |
|
八氢-2,6-喹啉二酮 | 1,3,4,4a,5,7,8,8a-octahydro-2,6-quinolinedione | 179685-97-3 | C9H13NO2 |
|
八乙二醇 | octaethylene glycol | 5117-19-1 | C16H34O9 |
|
克里唑替尼中间体 | 4-(4-{6-amino-5-[(R)-1-(2,6-dichloro-3-fluoro-phenyl)-ethoxy]-pyridin-3-yl}-pyrazol-1-yl)-piperidine-1-carboxylic acid tert-butyl ester | 877399-51-4 | C26H30Cl2FN5O3 |
|
克罗米芬 | Clomoxir | 88431-47-4 | C14H17ClO3 |
|
光敏增感剂 | 2,4-Oxazolidinedione, 5-[[4-(diphenylamino)phenyl]methylene]-3-(2-phenylethyl)- | 506426-96-6 | C30H24N2O3 |
|
偶氮苯-4-苯甲酸 | 4-(2-phenyldiazen-1-yl)benzoic acid | 1562-93-2 | C13H10N2O2 |
|
偶氮苯-4,4’-二羰酰氯 | azobenzene-4,4'-dicarbonyl dichloride | 10252-29-6 | C14H8Cl2N2O2 |
|
偶氮苯-3,3-二羧酸 | 3,3'-azodibenzoic acid | 621-18-1 | C14H10N2O4 |
|
偶氮二羧酸二苯酯 | azodicarboxylic acid diphenyl ester | 2449-14-1 | C14H10N2O4 |
|
假紫罗兰酮 | pseudoionone | 141-10-6 | C13H20O |
|
假尿嘧啶核苷 | Protoveratrine B | 124-97-0 | C41H63NO15 |
|
倍他米松环氧水解物 | 9β,11β-epoxy-17α,21-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione | 981-34-0 | C22H28O5 |
|
保特佐米蒎烷二醇酯 | N-{(1R)-3-methyl-1-[(3aS,4S,6S,7aS)-3a,5,5-trimethylhexahydro-4,6-methano-1,3,2-benzodioxaborol-2-yl]butyl}-Nα-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide | 205393-22-2 | C29H39BN4O4 |
|
保泰松 | 4-butyl-1,2-diphenylpyrazolidine-3,5-dione, compound with piperazine (1:1) | 4985-25-5 | C4H10N2*C19H20N2O2 |
|
依鲁替尼 | ibrutinib | 936563-96-1 | C25H24N6O2 |
|
依非韦伦相关物质B | Dihydro efavirenz, (E)- | 440124-96-9 | C14H11ClF3NO2 |
|
依西美坦中间体 | 6-methyleneandrost-4-ene-3,17-dione | 19457-55-7 | C20H26O2 |
|
依沙替康甲磺酸盐水合物 | exatecan mesylate dihydrate | 197720-53-9 | CH4O3S*C24H22FN3O4*2H2O |
|
依替米贝中间体 | (4S)-4-benzyl-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-1,3-oxazolidin-2-one | 852148-49-3 | C21H22FNO4 |
|
依普利酮中间体A2-2 | methyl hydrogen 17α-hydroxy-11α-(methylsulfonyl)oxy-3-oxopregn-4-ene-7α,21-dicarboxylate, γ-lactone | 192704-58-8 | C25H34O8S |
|
依拉司群中间体 | tert-butyl 4-(bromomethyl)phenethylcarbamate | 914103-95-0 | C14H20BrNO2 |
|
依拉司群 | RAD-1901 | 722533-56-4 | C30H38N2O2 |
|
依折麦布四氢吡喃 | (2R,3R,6S)-N,6-bis(4-fluorophenyl)-2-(4-hydroxyphenyl)-3,4,5,6-tetrahydro-2H-pyran-3-carboxamide | 1296129-15-1 | C24H21F2NO3 |
|
依托格鲁 | triethylene glycol diglycidyl ether | 1954-28-5 | C12H22O6 |
|
依度沙班杂质F 盐酸盐 | N1-{(1S,2R,4S)-2-Amino-4-[(dimethylamino)carbonyl]-cyclohexyl}-N2-(5-chloropyridin-2-yl)ethanediamide hydrochloride | 482375-18-8 | C16H22ClN5O3*ClH |
|
依度沙班A草酸盐一水合物 | tert-butyl {(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl}carbamate monooxalate monohydrate | 1353893-22-7 | C2H2O4*C14H27N3O3*H2O |
|
依度沙班A盐中间体 | ethyl (1S,3R,4R)-3-(tert-butoxycarbonylamino)-4-hydroxycyclohexane-1-carboxylate | 365997-33-7 | C14H25NO5 |
|
依帕司他杂质2 | ethyl 2-(4-oxo-2-thioxothiazolidin-3-yl)acetate | 23176-01-4 | C7H9NO3S2 |
|
依帕列净中间体 | (S)-(2-chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yl)oxy)phenyl)methanone | 915095-87-3 | C17H14ClIO3 |
|
依帕列净中间体 | (2-chloro-5-iodophenyl)(4-fluorophenyl)methanone | 915095-86-2 | C13H7ClFIO |
|
依奈骨化醇中间体 | 1α,25-dihydroxy-2-methylene vitamin D3 | 1428946-52-4 | C28H44O3 |
|
依喜替康中间体 | N-(8-amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalene-2-yl)acetamide | 182182-31-6 | C13H15FN2O2 |
|
依匹斯汀氢溴酸盐 | 3-amino-9,13b-dihydro-1H-dibenz<c,f>imidazo<1,5-a>azepine hydrobromide | 127786-29-2 | BrH*C16H15N3 |
|
依利格鲁司特中间体5 | (1R,2R)-2-amino-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-(pyrrolidin-1-yl)propan-1-ol | 491833-28-4 | C15H22N2O3 |
|
佛手苷内酯 | bergapten | 484-20-8 | C12H8O4 |
|
伐地考昔 | valdecoxib | 181695-72-7 | C16H14N2O3S |
|
伏立康唑 | (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol R-(-)-10-camphorsulphonate | 137234-71-0 | C10H16O4S*C16H14F3N5O |
|
伊马替尼间-甲基-哌嗪 | N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-3-((4-methylpiperazin-1-yl)methyl)benzamide | 1246819-59-9 | C29H31N7O |
|
伊菠胺-18-羧酸甲酯 | coronaridine | 467-77-6 | C21H26N2O2 |
|
伊曲康唑杂质41 | [(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl methanesulfonate | 854372-78-4 | C14H15Cl2N3O5S |
|
伊普吲哚 | iprindole | 5560-72-5 | C19H28N2 |
|
伊布替尼中间体N-2 | 3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | 330786-24-8 | C17H13N5O |
|
伊伐布雷定杂质68 | (S)-4,5-dimethoxy-1,2-dihydrocyclobutabenzene-1-carboxylic acid | 1220993-44-1 | C11H12O4 |
|
仲丁基喹啉 | 6-sec-butylquinoline | 65442-31-1 | C13H15N |
|
他氟前列素酸 | tafluprost acid | 209860-88-8 | C22H28F2O5 |
|
他发米帝司甲葡胺 | tafamidis meglumine | 951395-08-7 | C7H17NO5*C14H7Cl2NO3 |
|
他伐帕敦 | 1,5-dimethyl-6-(2-methyl-4-((3-(trifluoromethyl)pyridin-2-yl)-oxy)phenyl)pyrimidine-2,4(1H,3H)-dione | 1643489-24-0 | C19H16F3N3O3 |
|